CML - Philadelphia Chromosome
2 clinical trials · Condition
◉ Watch CML - Philadelphia Chromosome
| Record | Firm | Date |
|---|---|---|
| Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients (NCT03885830) | UNC Lineberger Comprehensive Cancer Center | 2019-06-20 |
| A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs (NCT03459534) | Il-Yang Pharm. Co., Ltd. | 2018-06-25 |
Track CML - Philadelphia Chromosome automatically
Every clearance here is in the API, with alerts when new ones post.